JENNA DAVIS: Open Payments
NPI 1871217935 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 9 payments from 5 companies in 2025. Trend: 2023 $1,843 · 2024 $467 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $78 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Celgene Corporation | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Ozempic, KISQALI, REBLOZYL, AIRSUPRA, Kerendia, BREZTRI.
Industry payments across SC — which companies pay providers there.
